Quality Management Optimizing HEDIS & STARSMedicare AdvantageApril 2, 2025

HEDIS measure: Statin Use in Persons with Diabetes (SUPD) 2025

Measure

This HEDIS® measure assesses the percentage of members with diabetes who take the most effective cholesterol lowering drugs to lower their risk of developing heart disease.

Refer to attachment to view full details

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-075415-24-CPN74739

ATTACHMENTS: HEDIS measure: Statin Use in Persons with Diabetes (SUPD) 2025 (pdf - 0.17mb)